Streptococcal pyomyositis of the psoas: Case reports and review

Pediatric Emergency Care

Volumn 22, Issue 4, 2006, Pages 250-253

  Kern, Leah ^a   Rassbach, Caroline ^a,b   Ottolini, Mary ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Group A beta hemolytic streptococcus; Psoas muscle; Pyomyositis

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CLAVULANIC ACID; CLINDAMYCIN; DOBUTAMINE; DOPAMINE; IMMUNOGLOBULIN; INOTROPIC AGENT; METHADONE; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; TICARCILLIN; TIMENTIN; VANCOMYCIN;

CASE REPORT; CHILD; CHILDHOOD DISEASE; DRUG DOSE REDUCTION; EARLY DIAGNOSIS; FEVER; HUMAN; ILIOPSOAS MUSCLE; LEG PAIN; MALE; PSOAS MUSCLE; PYOMYOSITIS; RARE DISEASE; REVIEW; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; VOMITING;

ANTI-BACTERIAL AGENTS; APPENDICITIS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEVER; HUMANS; LEUKOCYTE COUNT; MALE; MYOSITIS; PAIN; PELVIS; PSOAS MUSCLES; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TREATMENT OUTCOME; VOMITING;

EID: 33646828044     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pec.0000210177.48386.e7     Document Type: Review

References (21)

1. Christin L, Sarosi GA. Pyomyositis in North America: Case reports and review. Clin Infect Dis. 1992;15:668-677.
2. Grouse C. Pyomyositis in children in the United States. Rev Infect Dis. 1991;13:339-340.
3. Beck W, Grose C. Pyomyositis presenting as acute abdominal pain. Pediatr Infect Dis J. 1984;3(5):445-448.
4. Gubbay AJ, Isaacs D. Pyomyositis in children. Pediatr Infect Dis J. 2000;19:1009-1113.
5. Kaplan EL. Recent epidemiology of Group A streptococcal in North America and abroad: an overview. Pediatrics. 1996;97(6):945-948.
6. Adams EM, Gudmundsson S, Yocum DE, et al. Streptococcal myositis. Arch Intern Med. 1985;145:1020-1023.
7. MacLaurin JP. Spontaneous streptococcal myositis associated with disseminated intravascular coagulopathy. J Am Osteopath Assoc. 1977;76:675-682.
8. Wheeler DS, Vasquez WD, Vaux KK, et al. Streptococcal pyomyositis: case report and review. Pediatr Emerg Care. 1998;14(6):411-412.
9. Zervas SJ, Zemel LS, Romness MJ, et al. Streptococcus pyogenes pyomyositis. Pediatr Infect Dis J. 2002;21:166-168.
10. Daley AJ, Atkinson M, Nallusamy R. Group A streptococcal myositis. J Paediatr Child Health. 1999;35:588-590.
11. Torres-Martinez C, Mehta D, Butt A, et al. Streptococcus associated toxic shock. Arch Dis Child. 1992;67:126-130.
12. Harnden A, Lennon D. Serious suppurative Group A streptococcal infections in previously well children. Pediatr Infect Dis J. 1988;7:714-718.
13. Sanchez NC, Lancaster BA. A rare case of primary group A streptococcal peritonitis. Am J Surg. 2001;67(7):633-634.
14. Gillespie RS, Hauger SB, Holt RM. Primary group A streptococcal peritonitis in a previously healthy child. Scand J Infect Dis. 2002;34(11):847-848.
15. Bresee JS, Edwards MS. Psoas abscess in children. Pediatr Infect Dis J. 1990;9:201-206.
16. Song J, Letts ML, Monson R. Differentiation of psoas muscle abscess from septic arthritis of the hip in children. Clin Orthop. 2001;391:258-264.
17. Barza MJ, Brennick JB. A 33-Year-Old Man with a sore throat followed by swelling and pain in the leg. N Eng J M. 1995;333:113-119.
18. Stevens DL, Gibbons AE, Bergstrom R, et al. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis. 1988;158(1):23-28.
19. Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J. 1999;18:1096-1100.
20. Coyle EA, Cha R, Rybak MJ. Influences of linezolid, penicillin, and clindamycin, alone or in combination, on streptococcal pyrogenic exotoxin A release. Antimicro Agents Chemother. 2003;47(5):1752-1755.
21. Norrby-Teglund A, Low DE. Group A streptococcal toxic shock syndrome and necrotizing fasciitis. Curr Treat Options Infect Dis. 2003;5:419-442.